Check out your Company Bowl for anonymous work chats.
OPEN Health, the European Patients’ Forum (EPF), and the European Alliance of Neuromuscular Disorders Associations (EAMDA) join forces on a Delphi consensus panel project for patients focusing on Population, Intervention, Comparator, and Outcomes (PICO) scoping. From January 12th, 2025, a European Union (EU) regulation 2021/2282 (HTAR) will apply to evaluate the relative clinical effectiveness and safety of health technologies, starting from cancer medications and ATMP therapies. The regulation aims to foster joint work on Health Technology Assessments (HTAs) across the EU by establishing the creation of the Joint Clinical Assessment (JCA) that will be developed in parallel to EMA regulatory procedures. Click to read more.
OPEN Health today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine learning (ML) solutions provider that will work exclusively with OPEN Health. This alliance will see fusion's market-leading AI capabilities deployed across OPEN Health's extensive global client base, which includes 49 of the top 50 pharmaceutical companies. Click to read more.
Celebrate #MedCommsDay with us by tuning in to our latest podcast, in which OPEN Health experts discuss the evolving landscape of medical communications. Explore the latest trends, challenges, and innovations shaping the future of #MedComms and get valuable advice about starting your career in this exciting field! Click to listen the podcast.
At OPEN Health, we are dedicated to providing services that benefit our clients, employees, partners, and the communities in which we operate, all while maintaining a deep respect for the environment. Explore our Environmental, Social and Governance (ESG) pillars and the latest 2023 Sustainability Report here.
OPEN Health has launched OPEN X Health, a new practice focused on providing data-driven creativity to the pharmaceutical industry. OPEN X Health (OPEN X) launches after two years of investment and growth in the creative communications offering from OPEN Health. OPEN Health acquired ARK, the award-winning London-based healthcare agency, in 2021, combining it with its own creative division. This united team has grown from strength to strength in terms of talent, awards, and client wins, notably becoming the most awarded agency at the PM Society Digital Awards in 2022 and 2023. “The launch of the new OPEN X practice provides clear definition of OPEN Health’s exceptional creative offering, complementing the broad range of OPEN Health capabilities that unlock possibilities for our clients across the product lifecycle,” said Rob Barker, CEO of OPEN Health. Click to read more
January 22, 2024, London, UK – OPEN Health is pleased to announce the appointment of Steven Duryee as Chief Operating and Transformation Officer. In this role, Steve will be responsible for the execution of the strategic plan, large-scale transformation initiatives, driving growth in the US, and evolving OPEN Health’s go-to-market strategy. An experienced executive with over 30 years of expertise in the health and life sciences industries, Steve has held executive leadership positions at TriRadial Solutions, Meditrial, Wipro LLC, Synchronoss Technologies, Dell Enterprises, Capgemini, and Ciber Global. In addition to Steve’s proficiency in business development, operations, and technology, he has a proven track record in scaling and maturing business capabilities while growing global business revenue and operating profit in an accelerated manner. Click to read more.
OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is excited to announce a strategic collaboration with Nested Knowledge, a leading provider of AI-based SaaS platform solutions for systematic literature review and meta-analysis. Together, we aim to enhance the speed, efficiency, and depth of evidence synthesis, ultimately aiding biopharmaceutical researchers in making crucial healthcare decisions and bringing products to market quicker. “This collaboration underscores OPEN Health's unwavering commitment to leveraging innovative solutions and AI technologies for superior client delivery,” said Richard Jones, President of OPEN Health Evidence & Access. “We are excited to formalize our collaboration with Nested Knowledge and collectively bring market-leading evidence synthesis solutions to our clients.” Click to read more.
OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement, deepening the organization's existing commitment to building patient-first solutions. OPEN Health is combining the strength, expertise, and proven track record of the Px Group, a division of the CM Group which was acquired in 2022, and OPEN Health’s own patient engagement team into a unified global patient communications, patient research, and creative patient engagement partner. The combined team will be led by Cherie Myatt, alongside Senior Vice President Alexandra Dubois, Registered Health Psychologist and Cognitive Behavioral Therapist Dr. Sumira Riaz, and Patient Centricity Global Lead Gavin Jones. Myatt, co-founder of the CM Group, started to build out a patient engagement team in 2016 based on clients’ needs to connect and activate their patient communities. She and Dubois, an experienced marketer and rare disease advocate, launched a division of the agency focused exclusively on providing patient engagement solutions to clients in the life sciences industry, particularly those in rare and complex conditions. Dr. Sumira Riaz has led OPEN Health’s Patient Engagement practice in Europe for the past six years, with an industry-leading team of health psychologists and behavioral scientists. Click to read more.
OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, will be presenting innovative research at the upcoming ISPOR Europe conference in Copenhagen, Denmark. OPEN Health experts will contribute to the event through workshops, panel discussions, and 24 posters. Key themes of OPEN Health’s research presented this year are patient preference, advanced modeling methodologies, and HTA policy changes. The majority of OPEN Health’s Scientific Office will be onsite to discuss the role of HEOR science in shaping policy, including Dr. Elisabeth Fenwick, Chief Scientific Officer; Professor Ben van Hout, Scientific Founder; Dr. Marco Boeri, Director of Preference Research and scientific lead for Patient-Centered Outcomes; Emanuele Arcà, MSc, Senior Research Consultant in Strategic Market Access; and Maarten Treur, MSc, Vice President and Global Head of Modeling & Meta-Analysis. Click to read more.
Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice. Dom will be responsible for leading the company's overall creative strategy, with a specific focus on the creative communications practice, which specializes in data-driven creativity. By joining the OPEN Health executive leadership team, he will share this world-class, innovative approach throughout all of OPEN Health’s global practices, including scientific communications, patient engagement, and HEOR and market access. “Data-driven creativity is central to all our services, and Dom demonstrates an innate vision for driving it within OPEN Health. He embodies a unique perspective and a freshness, seamlessly blending digital-first thinking with creative vision, but always with a commercial focus,” said Rob Barker, OPEN Health Group CEO. Dom joined OPEN Health in 2021 through the acquisition of London-based creative agency ARK. He has a strong reputation in the industry, with a history of building successful healthcare agencies. In addition to 15 years’ experience in healthcare, he has worked with a diverse range of clients, including The Coca-Cola Company, Panasonic, Björk, and Ted Baker. His healthcare clients have included AZ, GSK, Alexion, BI, Takeda, Pfizer, and LEO. Click to read more.
